Cargando…
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells
Endoglin (ENG) is a single-pass transmembrane protein highly expressed on vascular endothelial cells, although low expression levels can be detected in many other cell types. Its extracellular domain can be found in circulation known as soluble endoglin (sENG). Levels of sENG are elevated in many pa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126157/ https://www.ncbi.nlm.nih.gov/pubmed/37095146 http://dx.doi.org/10.1038/s41598-023-33352-3 |
_version_ | 1785030178019213312 |
---|---|
author | Andersson-Rusch, Clara Liu, Bin Quist-Løkken, Ingrid Upton, Paul D. Olsen, Oddrun Elise Hella, Hanne Yang, Xudong Tong, Zhen Morrell, Nicholas W. Holien, Toril Li, Wei |
author_facet | Andersson-Rusch, Clara Liu, Bin Quist-Løkken, Ingrid Upton, Paul D. Olsen, Oddrun Elise Hella, Hanne Yang, Xudong Tong, Zhen Morrell, Nicholas W. Holien, Toril Li, Wei |
author_sort | Andersson-Rusch, Clara |
collection | PubMed |
description | Endoglin (ENG) is a single-pass transmembrane protein highly expressed on vascular endothelial cells, although low expression levels can be detected in many other cell types. Its extracellular domain can be found in circulation known as soluble endoglin (sENG). Levels of sENG are elevated in many pathological conditions, in particular preeclampsia. We have shown that while loss of cell surface ENG decreases BMP9 signaling in endothelial cells, knocking down ENG in blood cancer cells enhances BMP9 signaling. Despite sENG binding to BMP9 with high affinity and blocking the type II receptor binding site on BMP9, sENG did not inhibit BMP9 signaling in vascular endothelial cells, but the dimeric form of sENG inhibited BMP9 signaling in blood cancer cells. Here we report that in non-endothelial cells such as human multiple myeloma cell lines and the mouse myoblast cell line C2C12, both monomeric and dimeric forms of sENG inhibit BMP9 signaling when present at high concentrations. Such inhibition can be alleviated by the overexpression of ENG and ACVRL1 (encoding ALK1) in the non-endothelial cells. Our findings suggest that the effects of sENG on BMP9 signaling is cell-type specific. This is an important consideration when developing therapies targeting the ENG and ALK1 pathway. |
format | Online Article Text |
id | pubmed-10126157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101261572023-04-26 High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells Andersson-Rusch, Clara Liu, Bin Quist-Løkken, Ingrid Upton, Paul D. Olsen, Oddrun Elise Hella, Hanne Yang, Xudong Tong, Zhen Morrell, Nicholas W. Holien, Toril Li, Wei Sci Rep Article Endoglin (ENG) is a single-pass transmembrane protein highly expressed on vascular endothelial cells, although low expression levels can be detected in many other cell types. Its extracellular domain can be found in circulation known as soluble endoglin (sENG). Levels of sENG are elevated in many pathological conditions, in particular preeclampsia. We have shown that while loss of cell surface ENG decreases BMP9 signaling in endothelial cells, knocking down ENG in blood cancer cells enhances BMP9 signaling. Despite sENG binding to BMP9 with high affinity and blocking the type II receptor binding site on BMP9, sENG did not inhibit BMP9 signaling in vascular endothelial cells, but the dimeric form of sENG inhibited BMP9 signaling in blood cancer cells. Here we report that in non-endothelial cells such as human multiple myeloma cell lines and the mouse myoblast cell line C2C12, both monomeric and dimeric forms of sENG inhibit BMP9 signaling when present at high concentrations. Such inhibition can be alleviated by the overexpression of ENG and ACVRL1 (encoding ALK1) in the non-endothelial cells. Our findings suggest that the effects of sENG on BMP9 signaling is cell-type specific. This is an important consideration when developing therapies targeting the ENG and ALK1 pathway. Nature Publishing Group UK 2023-04-24 /pmc/articles/PMC10126157/ /pubmed/37095146 http://dx.doi.org/10.1038/s41598-023-33352-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Andersson-Rusch, Clara Liu, Bin Quist-Løkken, Ingrid Upton, Paul D. Olsen, Oddrun Elise Hella, Hanne Yang, Xudong Tong, Zhen Morrell, Nicholas W. Holien, Toril Li, Wei High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells |
title | High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells |
title_full | High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells |
title_fullStr | High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells |
title_full_unstemmed | High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells |
title_short | High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells |
title_sort | high concentrations of soluble endoglin can inhibit bmp9 signaling in non-endothelial cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126157/ https://www.ncbi.nlm.nih.gov/pubmed/37095146 http://dx.doi.org/10.1038/s41598-023-33352-3 |
work_keys_str_mv | AT anderssonruschclara highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT liubin highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT quistløkkeningrid highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT uptonpauld highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT olsenoddrunelise highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT hellahanne highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT yangxudong highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT tongzhen highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT morrellnicholasw highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT holientoril highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells AT liwei highconcentrationsofsolubleendoglincaninhibitbmp9signalinginnonendothelialcells |